# Ophthalmology (retina) Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jackie Robinson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML037-SYN
- Date: 2026-07-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marcus Delacroix-Hale, MD
- Calendar frame: modern shifted

- To: Priya Ostrowski-Lane, MD, Ophthalmology (retina)
- Urgency: Within 48 hours, by phone arrangement today; same-day attendance if a curtain over the vision or flashes appear

## Referral question

Blurred vision in both eyes for two months and new floaters in the right eye for four days in a 52-year-old man with type 2 diabetes for about fifteen years and an A1c of 10.4%. Snellen acuity 20/200 right and 20/80 left; the undilated view of the right fundus is poor. Please examine for proliferative retinopathy, vitreous hemorrhage, retinal detachment and macular edema, and treat as needed. **S**

## Questions for the consultant

1. What is the stage of retinopathy in each eye, is there macular edema, and is the right retina attached behind any hemorrhage?
2. What treatment do you advise now (anti-VEGF injections, panretinal photocoagulation, vitrectomy), and on what schedule?
3. How quickly should we lower his A1c, and should a GLP-1 receptor agonist such as semaglutide wait until the retina is stable?
4. Should he continue aspirin with a vitreous hemorrhage?
5. What can be done now for his daily vision, including reading, driving and managing insulin?
6. How often will he need retina visits, and what should bring him back at once?

## Pertinent history

Mr. Robinson has had type 2 diabetes for about fifteen years, treated with metformin 1,000 mg twice daily and insulin glargine 30 units at bedtime; A1c today 10.4%, random glucose 248 mg/dL. He has hypertension (152/92 today on lisinopril 20 mg), albuminuria (urine albumin-to-creatinine ratio 86 mg/g, eGFR 79), peripheral artery disease with claudication at one block, loss of protective sensation in both feet, and two mild strokes a year ago without lasting weakness; he takes aspirin 81 mg, and atorvastatin was increased today to 80 mg (LDL 142 mg/dL). He reports chest tightness on stairs; a cardiology evaluation with a stress test is being arranged. He has not had a dilated eye examination for more than two years. His eldest son died six weeks ago, and he is grieving. He cannot read print or drive safely now and is afraid of losing his sight. He asks whether he must stop aspirin. **S**

- Jackie Robinson was born on January 31, 1919, in Cairo, Georgia, to a family of sharecroppers. **D**
- On April 15, 1947, he played his first major league game for the Brooklyn Dodgers, ending more than sixty years of segregation in major league baseball. **D**
- His retirement from baseball was announced in January 1957; he then worked in business and as a spokesman and fundraiser for civil rights causes, including the NAACP. **D**
- He was diagnosed with diabetes at about 37, around the time he retired from baseball, and at first kept it private; two of his brothers also had diabetes. **D**
- By 1969, at 50, he had nerve and artery damage in his legs. **D**
- In 1970 he had two mild strokes. **D**
- His eldest son, Jackie Robinson Jr., was killed in an automobile accident on June 17, 1971, at 24. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin A1c: 10.4% (high); Glucose (random): 248 mg/dL (high); Sodium: 137 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 1.12 mg/dL; eGFR (CKD-EPI 2021, race-free): 79 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 86 mg/g (high); Total cholesterol: 226 mg/dL (high); LDL cholesterol: 142 mg/dL (high); HDL cholesterol: 38 mg/dL (low); Triglycerides: 230 mg/dL (high); ALT: 28 U/L; AST: 24 U/L; Hemoglobin: 13.9 g/dL; Platelets: 250 10*3/uL; Vitamin B12: 380 pg/mL; TSH: 1.8 mIU/L; PHQ-9: 9. All results are synthetic.

BP 152/92 mmHg; pulse 84 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 104 kg; BMI 32.1 kg/m². All vital signs are synthetic.

## Current medications

- Metformin 1,000 mg oral tablet, one tablet twice daily with meals **S**
- Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70 **S**
- Lisinopril 20 mg oral tablet, one tablet daily **S**
- Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake) **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes **S**

## Plan so far

- Glucose: continue metformin and basal insulin, titrated slowly by a written plan so that the A1c falls gradually; rescue glucagon; diabetes self-management education adapted for low vision (a talking glucose meter, an insulin pen with audible dose clicks, large-print plans). Guideline: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026) **S**
- Cardiovascular risk: atorvastatin increased to 80 mg, aspirin continued, baseline ECG; cardiology evaluation of exertional chest tightness with a pharmacologic stress test, since calf pain limits walking. Guideline: 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026) **S**
- Legs and feet: comprehensive foot examination today; ankle-brachial index; daily foot checks with a magnifying mirror and a bright lamp, protective shoes; podiatry. Guideline: 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease (2024) **S**
- Kidneys: repeat urine albumin and kidney function after any change in kidney medicines; no NSAIDs. Guideline: 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024) **S**
- Grief and mood: acknowledge the loss, PHQ-9 now and at three months, and an offer of the health center's grief counselor, which he accepted; call or text 988 if thoughts of self-harm ever arise. Guideline: 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026 (2026); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**
